VMP 41758211000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ambrisentan 10mg tablets
BNF code 0205010X0AAABAB
Virtual Therapeutic Moiety Ambrisentan
Date identifier became valid 9 May 2023
Previous product identifier 428480001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Ambrisentan
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Ambrisentan 10mg tablets (Accord-UK Ltd)
Ambrisentan 10mg tablets (Cipla EU Ltd)
Ambrisentan 10mg tablets (Viatris UK Healthcare Ltd)
Volibris 10mg tablets (GlaxoSmithKline UK Ltd)
Virtual Medicinal Product Packs
Ambrisentan 10mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_10.0.0_20241007000001, imported on 7th October 2024 at 04:53:31.

Feedback